Patent ID: 8642653

Claim:
A method for treating a disease or disorder selected from a group consisting of hyperlipidemia, hypertension, and obesity in a diabetic or obese patient, comprising administering to a diabetic or obese patient in need of such treatment a therapeutically effective amount of a compound selected from a group consisting of: t-butyl-1[9[1-(tert-butyoxycarbonyl)cyclopropyl]-5-oxononyl]-1-cyclopropanecarboxylate; 11-(1-carboxycyclopropyl)-2,2-dimethyl-7-oxoundecanoic acid; 1-[9-(1-carboxycyclopropyl)-5-oxononyl]-1-cyclopropanecarboxylic acid; 11-(1-carboxycyclobutyl)-2,2-dimethyl-7-oxoundecanoic acid; 1-[9-(1-carboxycyclobutyl)-5-oxononyl]-1-cyclobutanecarboxylic acid; 1-[9-(1-carboxycyclopentyl)-5-oxononyl]-1-cyclopentylcarboxylic acid; 13-(1-carboxycyclopropyl)-2,2-dimethyl-8-oxotridecanoic acid; 1-[11-(1-carboxycyclopropyl)-6-oxoundecyl]-1-cyclopropanecarboxylic acid; and 1-[11-(1-carboxycyclopentyl)-6-oxoundecyl]-1-cyclopentanecarboxylic acid; or a pharmaceutically acceptable salt thereof.